ODBORNÉ PUBLIKACE 2017

1. Ludka O, Štěpánová R,, Sert-Kuniyoshi F, Špinar J, Somers VK a Kára T. Differential likelihood of NSTEMI vs STEMI in patients with sleep apnea. International Journal of Cardiology, Clare (Ireland): Elsevier Ireland Ltd., 2017, roč. 248, DEC 1 2017, s. 64-68. ISSN 0167-5273. doi:10.1016/j.ijcard.2017.06.034.

2. Ohmann C, Banzi R, Canham S, et al Sharing and reuse of individual participant data from clinical trials: principles and recommendations. BMJ Open 2017;7:e018647. doi: 10.1136/bmjopen-2017-018647.

3. Hradecka I, Rihova B, Demlova R. The Cost Study of Cetuximab and Panitumumab in the First-Line Treatment of mCRC in the Czech Republic. Value in Health. 2017; Vol. 20, Issue 9:A426.

4. Duchnowska R, Sperinde J, Czartoryska-Arłukowicz B, Myśliwiec P, Winslow J, Radecka B, Petropoulos C, Demlova R, Orlikowska M, Kowalczyk A, Lang I, Ziółkowska B, Dębska-Szmich S, Merdalska M, Grela-Wojewoda A, Żawrocki A, Biernat W, Huang W, Jassem J. Predictive value of quantitative HER2, HER3 and p95HER2 levels in HER2-positive advanced breast cancer patients treated with lapatinib following progression on trastuzumab. Oncotarget. 2017 Oct 24;8(61):104149-104159.

5. Brinkman DJ, Tichelaar J, Mokkink LB, Christiaens T, Likic R, Maciulaitis R, Costa J, Sanz EJ, Maxwell SR, Richir MC, van Agtmael MA; Education Working Group of the European Association for Clinical Pharmacology and Therapeutics (EACPT); its affiliated Network of Teachers in Pharmacotherapy (NOTIP). Key learning outcomes for clinical pharmacology and therapeutics education in Europe: A modified Delphi study. Clin Pharmacol Ther. 2017 Dec 5.

(Více ZDE)

6. Vychytilova-Faltejskova P, Merhautova J, Machackova T, Gutierrez-Garcia I, Garcia-Solano J, Radova L, Brchnelova D, Slaba K, Svoboda M, Halamkova J, Demlova R, Kiss I, Vyzula R, Conesa-Zamora P, Slaby O. MiR-215-5p is a tumor suppressor in colorectal cancer targeting EGFR ligand epiregulin and its transcriptional inducer HOXB9. Oncogenesis. 2017 Dec 4;6(11):5. (Více ZDE)

7. Drazanova E, Ruda-Kucerova J, Kratka L, Horska K, Demlova R, Starcuk Z Jr, Kasparek T. Poly(I:C) model of schizophrenia in rats induces sex-dependent functional brain changes detected by MRI that are not reversed by aripiprazole treatment. Brain Res Bull. 2017 Nov 16;137:146-155. (Více ZDE)

8. Horska K, Ruda-Kucerova J, Drazanova E, Karpisek M, Demlova R, Kasparek T, Kotolova H. Aripiprazole-induced adverse metabolic alteration in polyI:C neurodevelopmental model of schzophrenia in rats. Neuropharmacology. 2017 Jun 13;123:148-158.

9. Demlová R, Hejnová R. Atezolizumab. Acta Medicinae. 11:2017

10. Hradecká I, Říhová B a Demlová R. The Cost Study of Cetuximab and Panitumumab in The First-Line Treatment of Mcrc in The Czech Republic. 2017. ISSN 1098-3015

11. Součková L, Johaník J. CZECRIN – the national infrastructure supporting academic clinical trials, Elixir CZ Annual Conference 2017, str. 21 ISBN978-80-86241-57-9

12. Součková L, Štěrba J, Demlová R, Pavelka Z. The Experience with the targeted cancer therapy in paediatric patients – from the perspective of clinical pharmacist, The 13th Congress of the European Association for Clinical Pharmacology and Therapeutics, 24.-27.6.2017, Praha

13. FĚDOROVÁ, Lenka, Lenka ZDRAŽILOVÁ DUBSKÁ, Kateřina PILÁTOVÁ, Peter MÚDRY, Pavel MAZÁNEK, Zdeněk PAVELKA, Eva HLAVÁČKOVÁ, Jaroslav ŠTĚRBA, Lucie FLAJŠAROVÁ, Regina DEMLOVÁ a Dalibor VALÍK. Immunomonitoring of patients treated with personalized dendritic cell-based vaccine. 2017. ISSN 0923-7534. Annals of Oncology (2017) 28 (suppl_11): xi6-xi29.

14. Mazánek P. RENETA trial – CEPOETA clinical study. 12th Regional Central-Eastern/South-Eastern European Pediatric Oncohematology Meeting, Abstract book, 28.-30.9.2017

15. Mudrý P. Autologous dendritic cell vaccine for children with relapsed/refractory and very high risk solid tumors and lymphomas – clinical aspects, 12th Regional Central-Eastern/South-Eastern European Pediatric Oncohematology Meeting, Abstract book, 28.-30.9.2017

16. Valik D., Autologous dendritic cell vaccine for children with relapsed/refractory and very high risk solid tumors and lymphomas – immunological and biological aspects, 12th Regional Central-Eastern/South-Eastern European Pediatric Oncohematology Meeting, Abstract book, 28.-30.9.2017

K personalizaci obsahu, poskytování funkcí sociálních médií a analýze naší návštěvnosti využíváme soubory cookie.

Používáním webu s tím souhlasíte.

Zásady ochrany osobních údajů

  • LinkedIn - Gray Circle
  • Facebook - Grey Circle